Skip to Main Content

Paper Details

Phase 1 trial to model primary, secondary, and tertiary dengue using a monovalent vaccine.
BMC Infect Dis
0
2023
Author NameAffiliation
Bradford J WoodInterventional Radiology and Center for Interventional Oncology, NIH Clinical Center and National Cancer Institute, National Institutes of Health
  • 1 - 1

Datasets

Release 1.2